Goldman Sachs’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
|
|||||
|
2025
Q1 | $361K | Sell |
|
|||||
|
2024
Q4 | $676K | Sell |
|
|||||
|
2024
Q3 | $2.32M | Buy |
|
|||||
|
2024
Q2 | $2.19M | Buy |
|
|||||
|
2024
Q1 | $664K | Sell |
|
|||||
|
2023
Q4 | $488K | Sell |
|
|||||
|
2023
Q3 | $611K | Sell |
|
|||||
|
2023
Q2 | $749K | Buy |
|
|||||
|
2023
Q1 | $739K | Sell |
|
|||||
|
2022
Q4 | $2.45M | Sell |
|
|||||
|
2022
Q3 | $3.53M | Buy |
|
|||||
|
2022
Q2 | $2.67M | Buy |
|
|||||
|
2022
Q1 | $2.65M | Buy |
|
|||||
|
2021
Q4 | $5.48M | Sell |
|
|||||
|
2021
Q3 | $8.25M | Sell |
|
|||||
|
2021
Q2 | $10.6M | Buy |
|
|||||
|
2021
Q1 | $9.2M | Sell |
|
|||||
|
2020
Q4 | $17.5M | Buy |
|
|||||
|
2020
Q3 | $15.5M | Sell |
|
|||||
|
2020
Q2 | $38.6M | Sell |
|
|||||
|
2020
Q1 | $32.4M | Sell |
|
|||||
|
2019
Q4 | $42.2M | Buy |
|
|||||
|
2019
Q3 | $23.5M | Buy |
|
|||||
|
2019
Q2 | $30.9M | Buy |
|
|||||
|
2019
Q1 | $26.6M | Sell |
|
|||||
|
2018
Q4 | $28.8M | Sell |
|
|||||
|
2018
Q3 | $69.9M | Sell |
|
|||||
|
2018
Q2 | $70.5M | Sell |
|
|||||
|
2018
Q1 | $160M | Buy |
|
|||||
|
2017
Q4 | $37.8M | Sell |
|
|||||
|
2017
Q3 | $22.8M | Buy |
|
|||||
|
2017
Q2 | $15.6M | Buy |
|
|||||
|
2017
Q1 | $15.1M | Buy |
|
|||||
|
2016
Q4 | $5.89M | Sell |
|
|||||
|
2016
Q3 | $14.4M | Buy |
|
|||||
|
2016
Q2 | $5.62M | Buy |
|
|||||
|
2016
Q1 | $5.04M | Sell |
|
|||||
|
2015
Q4 | $7.79M | Buy |
|
|||||
|
2015
Q3 | $4.17M | Sell |
|
|||||
|
2015
Q2 | $5.6M | Sell |
|
|||||
|
2015
Q1 | $6.23M | Buy |
|
|||||
|
2014
Q4 | $5.04M | Buy |
|
|||||
|
2014
Q3 | $3.7M | Sell |
|
|||||
|
2014
Q2 | $4.55M | Buy |
|
|||||
|
2014
Q1 | $3.75M | Buy |
|
|||||
|
2013
Q4 | $3.02M | Sell |
|
|||||
|
2013
Q3 | $3.92M | Buy |
|
|||||
|
2013
Q2 | $3.32M | Buy |
|